(FATE) Fate Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Fate Therapeutics | (FATE) share price targets
Complete technical analysis of Fate Therapeutics (FATE) by charts plus indicators, forecast predictions and share price targets for Fate Therapeutics (FATE)
Fate Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-09 View latest technical analysis
10 day averaged volume of Fate Therapeutics is 1955634
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Fri Aug 2024 | 3.37 | 3.64 | 3.71 | 3.32 | 1.412 times |
| 08 Thu Aug 2024 | 3.62 | 4.00 | 4.09 | 3.50 | 1.696 times |
| 07 Wed Aug 2024 | 3.98 | 4.40 | 4.47 | 3.90 | 0.691 times |
| 06 Tue Aug 2024 | 4.29 | 4.23 | 4.61 | 4.03 | 0.701 times |
| 05 Mon Aug 2024 | 4.19 | 4.11 | 4.55 | 4.05 | 1.03 times |
| 02 Fri Aug 2024 | 4.63 | 4.48 | 4.66 | 4.34 | 1.264 times |
| 01 Thu Aug 2024 | 4.88 | 5.35 | 5.49 | 4.87 | 0.922 times |
| 31 Wed Jul 2024 | 5.33 | 5.15 | 5.75 | 5.02 | 1.03 times |
| 30 Tue Jul 2024 | 5.13 | 5.41 | 5.58 | 5.07 | 1.258 times |
| 29 Mon Jul 2024 | 5.41 | 5.43 | 5.65 | 5.32 | 0.67 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 3.2, for a target of 4 or 4.62
Share price targets for Fate Therapeutics (FATE)
| Target Type | Value |
| Downside Target | 3.03 |
| Downside Target | 3.10 |
| Downside Target | 3.32 |
| Upside Target | 3.55 |
| Upside Target | 3.71 |
| Upside Target | 4.16 |
| Upside Target | 4.34 |
| Upside Target | 4.54 |
| Upside Target | 5.00 |
| Upside Target | 5.49 |
| Upside Target | 5.75 |
| Upside Target | 5.92 |
| Upside Target | 7.35 |
Intraday share price targets for Fate Therapeutics (FATE)
| Target Type | Value |
| Downside Intraday Target | 2.92 |
| Downside Intraday Target | 2.48 |
| Upside Intraday Target | 4.21 |
| Upside Intraday Target | 5.06 |
| Upside Intraday Target | 3.77 |
Weekly technical analysis of Fate Therapeutics (FATE)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Fri Aug 2024 | 3.37 | 4.11 | 4.61 | 3.32 | 1.075 times |
| 02 Fri Aug 2024 | 4.63 | 5.43 | 5.75 | 4.34 | 0.948 times |
| 26 Fri Jul 2024 | 5.44 | 4.33 | 5.92 | 4.16 | 0.625 times |
| 19 Fri Jul 2024 | 4.27 | 3.67 | 5.00 | 3.55 | 2.222 times |
| 12 Fri Jul 2024 | 3.61 | 3.19 | 3.71 | 3.03 | 4.365 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Fate Therapeutics (FATE)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Fri Aug 2024 | 3.37 | 5.35 | 5.49 | 3.32 | 0.331 times |
| 31 Wed Jul 2024 | 5.33 | 3.30 | 5.92 | 3.03 | 0.977 times |
| 28 Fri Jun 2024 | 3.28 | 3.69 | 4.19 | 3.10 | 0.843 times |
| 31 Fri May 2024 | 3.68 | 3.95 | 4.54 | 3.34 | 1.052 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Fate Therapeutics (FATE)
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Fate Therapeutics ( (FATE) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Fate Therapeutics in short term and the sell signal is strong.
Fate Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Fate Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Fate Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.39 and Fate Therapeutics (FATE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Fate Therapeutics (FATE) stock. Volume based technical analysis of Fate Therapeutics (FATE) stock is negative.
Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Fate Therapeutics ( (FATE) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Fate Therapeutics ( (FATE) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Fate Therapeutics in short term and the sell signal is strong.
Fate Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Fate Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Fate Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.39 and Fate Therapeutics (FATE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Fate Therapeutics (FATE) stock. Volume based technical analysis of Fate Therapeutics (FATE) stock is negative.
Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.